International Clinical Trial: Artificial Intelligence-Assisted Pathological Diagnosis Technology Enhances the Quality and Efficiency of Tumor Patient Care-Development and Validation of an Early Warning Model for Hereditary Endocrine Tumor Syndromes Based on Multi-Omics and Multimodal Information

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122235) titled 'Artificial Intelligence-Assisted Pathological Diagnosis Technology Enhances the Quality and Efficiency of Tumor Patient Care-Development and Validation of an Early Warning Model for Hereditary Endocrine Tumor Syndromes Based on Multi-Omics and Multimodal Information' on April 10.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Condition: Genetic tumour syndromes

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-10

Target Sample Size: Genetic Endocrine Tumor Sy...